Overview: Electrolytes Serum Panel
Introduction: The Electrolytes Serum Panel is a diagnostic tool designed to assess electrolyte balance using serum samples. In India, electrolyte imbalances (hyponatremia, hyperkalemia, hypocalcemia, hypomagnesemia) are frequent in CKD, heart failure, dehydration, diarrhea, diuretic use, and tropical diseases (dengue, cholera). Prevalence is high in hospitalized patients (~20-30 percent in critical care), with rural/low-SES populations at greater risk due to malnutrition, poor sanitation, and delayed care. High morbidity from underdiagnosis leading to seizures, arrhythmias, muscle weakness, or coma. Per biochemistry practices aligned with ICMR and Indian Society of Nephrology guidelines, the test employs spectrophotometry for sodium, potassium, chloride over 1-2 days with high accuracy, valuable for routine metabolic evaluation and acute care. This diagnostic falls under metabolic screening and targets patients with confusion, edema, weakness, or renal/cardiac issues, addressing accurate detection to guide fluid/electrolyte correction. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise identification and reducing life-threatening complications. Its serum-based approach ensures reliable performance in India's diverse laboratory settings.
Other Names: Electro Serum Pnl.
FDA Status: FDA approved, CLIA certified for biochemistry, compliant with 2025 standards.
Historical Milestone: Serum electrolyte panel standard; in India, essential in emergency and renal protocols.
Purpose: The test assesses 3 parameters including sodium to guide electrolyte balance evaluation, detect imbalances, inform therapy.
Test Parameters: 1. Sodium, 2. Potassium, 3. Chloride.
Pretest Condition: Fasting 10-12 hours recommended; patients should report symptoms or risk factors.
Specimen: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.
Sample Stability at Room Temperature: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.
Sample Stability at Refrigeration: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.
Sample Stability at Frozen: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.
Medical History: Patients should provide details on symptoms (confusion, weakness), diuretics, renal/heart conditions, recent illness.
Consent: Written informed consent is required, detailing the test's purpose, potential risks of untreated imbalances including seizures or arrhythmias, benefits of early detection, and minimal discomfort from venipuncture.
Procedural Considerations: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store kits according to manufacturer specifications to ensure reliability.
Factors Affecting Result Accuracy: Delays beyond stability periods, improper storage conditions, hemolysis, or recent meals can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.
Clinical Significance: Abnormal levels indicate imbalance, necessitating specialist input. Normal may require follow-up in high-risk.
Specialist Consultation: Nephrologists or physicians should be consulted for management.
Additional Supporting Tests: Urine electrolytes, arterial blood gas for confirmation.
Test Limitations: Does not assess intracellular shifts; comprehensive approach required.
References: Indian Journal of Nephrology 2024, Electrolyte Studies India 2023.
